medline.ch Onkologie Gynäkologische Tumoren

	Ovarian Cancer Arora T, Mullangi S, Lekkala MR, Arora T, Mullangi S, Lekkala MR. PMID: 33620837 [PubMed]
	The role of altered long noncoding RNAs in overall survival of ovarian cancer: A systematic review and meta-analysis. Pathol Res Pract Seyed Hosseini E, Alizadeh Zarei M, Haddad Kashani H, Milajerdi A, Zare Dehghanani Z, Hassani Bafrani H, Nikzad H. PMID: 33621920 [PubMed - as supplied by publisher]
	Molecular mechanism study of BPAF-induced proliferation of ERÎ±-negative SKBR-3 human breast cancer cells in vitro/in vivo. Sci Total Environ Lei B, Xu L, Tang Q, Sun S, Yu M, Huang Y. PMID: 33621883 [PubMed - as supplied by publisher]
	Examination of incidence, mortality and disability-adjusted life years and risk factors of breast cancer in 49 Asian countries, 1990-2019: estimates from Global Burden of Disease Study 2019. Jpn J Clin Oncol Sharma R. PMID: 33621341 [PubMed - as supplied by publisher]
	Correction: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells. PLoS One Wanandi SI, Limanto A, Yunita E, Syahrani RA, Louisa M, Wibowo AE, Arumsari S. PMID: 33621270 [PubMed - as supplied by publisher]
	Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study. Cancer Mukama T, Kharazmi E, Sundquist K, Sundquist J, Fallah M. PMID: 33620751 [PubMed - as supplied by publisher]
	Survival of women diagnosed with breast cancer and who have survived a previous cancer. Breast Cancer Res Treat Pruitt SL, Zhu H, Heitjan DF, Rahimi A, Maddineni B, Tavakkoli A, Halm EA, Gerber DE, Xiong D, Murphy CC. PMID: 33620590 [PubMed - as supplied by publisher]
	Association of Obesity with Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis. J Natl Cancer Inst Lohmann AE, Soldera SV, Pimentel I, Ribnikar D, Ennis M, Amir E, Goodwin PJ. PMID: 33620467 [PubMed - as supplied by publisher]
	Breast Cancer Screening with Abbreviated Breast MRI: 3-year Outcome Analysis. Radiology Kwon MR, Choi JS, Won H, Ko EY, Ko ES, Park KW, Han BK. PMID: 33620293 [PubMed - as supplied by publisher]
	Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY study. Jpn J Clin Oncol Shao Z, Tseng LM, Huang CS, Pang D, Yang Y, Li W, Liao N, Geng C, Zhang Q, Xu B, Liu D, Kwong A, et al (continued in the appendix).. PMID: 33619550 [PubMed - as supplied by publisher]
	Hysterectomy and risk of breast, colorectal, thyroid and kidney cancer - an Australian data linkage study. Cancer Epidemiol Biomarkers Prev Wilson LF, Tuesley KM, Webb PM, Dixon-Suen SC, Stewart LM, Jordan SJ. PMID: 33619026 [PubMed - as supplied by publisher]
	Iron intake with the risk of breast cancer among Chinese women: a case-control study. Public Health Nutr Liu KY, Feng XL, Mo XF, Lin FY, Zhang X, Huang CY, Abulimiti A, Li L, Zhang CX. PMID: 33618790 [PubMed - as supplied by publisher]
	High-intensity interval training in breast cancer survivors: a systematic review. BMC Cancer Tsuji K, Matsuoka YJ, Ochi E. PMID: 33618699 [PubMed - in process]
	Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer. BMC Cancer Berger K, Rhost S, Rafnsdóttir S, Hughes É, Magnusson Y, Ekholm M, Stål O, Rydén L, Landberg G. PMID: 33618683 [PubMed - in process]
	Two-year toxicity of simultaneous integrated boost in hypofractionated prone breast cancer irradiation: comparison with sequential boost in a randomized trial. Radiother Oncol Van Hulle H, Desaunois E, Vakaet V, Paelinck L, Schoepen M, Post G, Van Greveling A, Speleers B, Mareel M, De Neve W, Monten C, Deseyne P, Veldeman L. PMID: 33617910 [PubMed - as supplied by publisher]
	Survival Outcomes of Breast Cancer in Sudanese Women: A Hospital-Based Study. JCO Glob Oncol Muddather HF, Elhassan MMA, Faggad A. PMID: 33617296 [PubMed - in process]
	DTX3 copy number increase in breast cancer: a study of associations to molecular subtype, proliferation and prognosis. Breast Cancer Res Treat Valla M, Opdahl S, Ytterhus B, Bofin AM. PMID: 33616774 [PubMed - as supplied by publisher]
	Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study. Breast Cancer Res Treat Tang M, Schaffer AL, Kiely BE, Daniels B, Lee CK, Simes RJ, Pearson SA. PMID: 33616773 [PubMed - as supplied by publisher]
	Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator. Ann Surg Oncol Jonczyk MM, Fisher CS, Babbitt R, Paulus JK, Freund KM, Czerniecki B, Margenthaler JA, Losken A, Chatterjee A. PMID: 33616770 [PubMed - as supplied by publisher]
	The Clinical Application Value of RDW, CA153, and MPV in Breast Cancer. Clin Lab Lu F, Pan S, Qi Y, Li X, Wang J. PMID: 33616344 [PubMed - in process]

Artikel 1 - 20 / 236820

Seite 1 von 11841

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung